Search

Your search keyword '"Hessamfar, Mojgan"' showing total 44 results

Search Constraints

Start Over You searched for: Author "Hessamfar, Mojgan" Remove constraint Author: "Hessamfar, Mojgan"
44 results on '"Hessamfar, Mojgan"'

Search Results

1. Exposure to COVID-19 Pandemic-Related Stressors and Their Association With Distress, Psychological Growth and Drug Use in People With HIV in Nouvelle Aquitaine, France (ANRS CO3 AQUIVIH-NA Cohort-QuAliV-QuAliCOV Study)

2. Humoral response after mRNA COVID-19 primary vaccination and single booster dose in people living with HIV compared to controls: A French nationwide multicenter cohort study—ANRS0001s COV-POPART

3. Longitudinal trends in causes of death among adults with HIV on antiretroviral therapy in Europe and North America from 1996 to 2020: a collaboration of cohort studies

6. Long-term follow-up of HIV-1 multi-drug-resistant treatment-experienced participants treated with etravirine, raltegravir and boosted darunavir: towards drug-reduced regimen? ANRS CO3 Aquitaine Cohort 2007–2018

8. Discrimination of the Veterans Aging Cohort Study Index 2.0 for Predicting Cause-specific Mortality Among Persons With HIV in Europe and North America

9. Enhancing HIV Pre-Exposure Prophylaxis (PrEP) Coverage Through Primary Care Initiation: A French Nationwide Study

10. Discrimination of the Veterans Aging Cohort Study Index 2.0 for Predicting Cause-specific Mortality Among Persons With HIV in Europe and North America.

11. Time to treatment initiation and HIV viral suppression in people diagnosed with HIV-1 during COVID-19 pandemic in ex-Aquitaine, France (ANRS CO3 AQUIVIH-NA Cohort-QuAliCOV Study)

13. Contribution of alcohol use in HIV/hepatitis C virus co-infection to all-cause and cause-specific mortality: A collaboration of cohort studies

14. Contribution of alcohol use in HIV/hepatitis C virus co-infection to all-cause and cause-specific mortality:A collaboration of cohort studies

15. Time to Treatment Initiation and HIV Viral Suppression in People Diagnosed With HIV-1 During COVID-19 Pandemic in Ex-Aquitaine, France (ANRS CO3 AQUIVIH-NA Cohort-QuAliCOV Study).

16. A case of lenacapavir use for preventing mother-to-child HIV transmission.

21. Effect of Cytomegalovirus-Induced Immune Response, Self Antigen—Induced Immune Response, and Microbial Translocation on Chronic Immune Activation in Successfully Treated HIV Type 1—Infected Patients: The ANRS CO3 Aquitaine Cohort

22. A highly virulent variant of HIV-1 circulating in the Netherlands

23. Outcome of Progressive Multifocal Leukoencephalopathy Treated by Interleukin-7

25. Safety of hydroxychloroquine and darunavir or lopinavir in COVID-19 infection

26. Safety of hydroxychloroquine and darunavir or lopinavir in COVID-19 infection

30. Incidence of sexually transmitted infections during pre-exposure prophylaxis for HIV: a worrying outcome at 2 years!

31. Elvitegravir–Cobicistat–Emtricitabine–Tenofovir Alafenamide Single-tablet Regimen for Human Immunodeficiency Virus Postexposure Prophylaxis.

32. Timing of combined antiretroviral treatment initiation in male and female migrants living with HIV in Western Europe

34. Switch to Rilpivirine/Emtricitabine/Tenofovir Single-Tablet Regimen of Human Immunodeficiency Virus-1 RNA-Suppressed Patients, Agence Nationale de Recherches sur le SIDA et les Hépatites Virales CO3 Aquitaine Cohort, 2012–2014

35. Acoustic Radiation Force Impulse (ARFI) and Transient Elastography (TE) for evaluation of liver fibrosis in HIV-HCV co-infected patients

37. High decay of blood HIV reservoir when tenofovir/emtricitabine/elvitegravir/cobicistat is initiated during the acute primary HIV infection.

38. Severe Morbidity According to Sex in the Era of Combined Antiretroviral Therapy: The ANRS CO3 Acquitaine Cohort.

39. AIDS and non-AIDS severe morbidity associated with hospitalizations among HIV-infected patients in two regions with universal access to care and antiretroviral therapy, France and Brazil, 2000-2008: hospital-based cohort studies.

40. Effect of Cytomegalovirus-Induced Immune Response, Self Antigen–Induced Immune Response, and Microbial Translocation on Chronic Immune Activation in Successfully Treated HIV Type 1–Infected Patients: The ANRS CO3 Aquitaine Cohort.

41. Sex Differences in Overall and Cause-Specific Mortality among HIV-Infected Adults on Antiretroviral Therapy in Europe, Canada and the US

42. AIDS and non-AIDS severe morbidity associated with hospitalizations among HIV-infected patients in two regions with universal access to care and antiretroviral therapy, France and Brazil, 2000-2008: hospital-based cohort studies.

43. Contribution of alcohol use in HIV/hepatitis C virus co-infection to all-cause and cause-specific mortality: A collaboration of cohort studies.

44. Chronic viral hepatitis is associated with low bone mineral density in HIV-infected patients, ANRS CO 3 Aquitaine Cohort.

Catalog

Books, media, physical & digital resources